# Efficacy and Safety of Liraglutide Versus Sulphonylurea Both in Combination With Metformin During Ramadan in Subjects With Type 2 Diabetes

> **NCT01917656** · PHASE4 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 343 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** liraglutide
- **DRUG:** metformin
- **DRUG:** sulphonylurea

## Key facts

- **NCT ID:** NCT01917656
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01-09
- **Primary completion:** 2014-09-01
- **Final completion:** 2014-09-04
- **Target enrollment:** 343 (ACTUAL)
- **Last updated:** 2017-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01917656

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01917656, "Efficacy and Safety of Liraglutide Versus Sulphonylurea Both in Combination With Metformin During Ramadan in Subjects With Type 2 Diabetes". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01917656. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*